Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

Published:2005-10-25 Issue:10 Volume:93 Page:1117-1121
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kim J G,Sohn S K,Kim D H,Baek J H,Jeon S B,Chae Y S,Lee K B,Park J S,Sohn J H,Kim J C,Park I K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602849.pdf

Reference29 articles.

1. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, Eliachar I, Strome M, Larto MA (2000) Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88: 876–883

2. Adelstein DJ, Li Y, Adams GL, Wagner Jr H, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92–98

3. Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17: 485–493

4. Brizel D, Albers M, Fisher S, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798–1804

5. Browman G, Cripps C, Hodson D, Eapen L, Sathya J, Levine MN (1994) Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12: 2648–2653

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?;Journal of Clinical Medicine;2022-09-23

2. Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects;World Journal of Surgical Oncology;2021-09-17

3. Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study;Journal of Global Oncology;2017-10

4. Capecitabine for treating head and neck cancer;Expert Opinion on Investigational Drugs;2016-05-09

5. Concurrent Chemoradiotherapy with Capecitabine/Cisplatin versus 5-Fluorouracil/Cisplatin in Resectable Laryngohypopharyngeal Squamous Cell Carcinoma;Ear, Nose & Throat Journal;2016-02